Global Health Ltd
Fri 29/08/2025,15:57:43 | NSE : MEDANTA
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 1405.00
Previous Close
₹ 1399.90
Volume
155446
Mkt Cap ( Rs. Cr)
₹36931.80
High
₹ 1409.70
Low
₹ 1365.30
52 Week High
₹ 1456.50
52 Week Low
₹ 935.50
Book Value Per Share
₹ 116.88
Dividend Yield
0.00
Face Value
₹ 2.00
What’s Your Call?
Collective community sentiment on Global Health Ltd
Your Vote -
Buy
38.10%
Hold
52.38%
Sell
9.52%
38.10%
42 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
100%
Sell Order Quantity
0%
Bid Price
Qty
1374.00
10
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
10
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts Global Health Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Global Health - Analysts/Institutional Investor Meet/Con. Call Updates
-
Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Global Health - Copy of Newspaper Publication
-
Global Health - Updates
-
Global Health - Letter To Shareholders Providing The Weblink Of Annual Report For The FY 2024-25
-
Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Global Health - Analysts/Institutional Investor Meet/Con. Call Updates
-
Global Health - Business Responsibility and Sustainability Reporting (BRSR)
-
Global Health - Notice Of 21St Annual General Meeting Scheduled To Be Held On Friday, September 19, 2025 Through Video Confer
-
Global Health - Reg. 34 (1) Annual Report.
-
Global Health - Shareholders meeting
-
Global Health - Copy of Newspaper Publication
-
Global Health - Analysts/Institutional Investor Meet/Con. Call Updates
-
Global Health - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
-
Global Health - Analysts/Institutional Investor Meet/Con. Call Updates
-
Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Global Health - Analysts/Institutional Investor Meet/Con. Call Updates
-
Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Global Health has declared 25% Final dividend for the financial year March 2025
-
Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
-
Global Health - Analysts/Institutional Investor Meet/Con. Call Updates
-
Global Health - Copy of Newspaper Publication
-
Global Health - Press Release
-
Global Health - Analysts/Institutional Investor Meet/Con. Call Updates
-
Global Health - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Global Health - Announcement under Regulation 30 (LODR)-Investor Presentation
-
Global Health - Record Date
-
Global Health - Change in Director(s)
-
Global Health - Change in Auditors
-
Global Health - Outcome of Board Meeting
-
Global Health - Announcement under Regulation 30 (LODR)-Date of payment of Dividend
-
Global Health - Fixation Of Record Date For Declaration Of Dividend
-
Global Health Q1 net profit jumps 57.83% at Rs 151.96 cr
-
Global Health - Announcement under Regulation 30 (LODR)-Change in Management
-
Global Health - Announcement under Regulation 30 (LODR)-Change in Directorate
-
Global Health - Results For The Quarter Ended June 30, 2025
-
Global Health - Board Meeting Outcome for Board Meeting Outcome For Intimation Under Regulation 30 Of SEBI Listing Regulatio
-
Global Health - ESOP/ESOS/ESPS
-
Global Health - Announcement under Regulation 30 (LODR)-Meeting Updates
-
Global Health - Analysts/Institutional Investor Meet/Con. Call Updates
-
Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Global Health - Board Meeting Intimation for Intimation Under Regulation 29 Of Listing Regulations
-
Global Health - ESOP/ESOS/ESPS
-
Global Health - Capacity addition
-
Global Health - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
-
Global Health - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('
-
Global Health - Commencement of commercial production/operations
-
Global Health - Intimation Under Regulation 30 Of The Listing Regulations.
-
Global Health has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2025
-
Global Health - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 201
-
Global Health - Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
-
Global Health - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Global Health - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Global Health - Trading Window-XBRL
-
Global Health - Trading Window
-
Global Health - Alteration Of Capital and Fund Raising-XBRL
-
Global Health - ESOP/ESOS/ESPS
-
Global Health - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
-
Global Health - Disclosure under SEBI Takeover Regulations
-
Global Health - Clarification - Financial Results
-
Global Health - Analysts/Institutional Investor Meet/Con. Call Updates
-
Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Global Health - Analysts/Institutional Investor Meet/Con. Call Updates
-
Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Global Health - Analysts/Institutional Investor Meet/Con. Call Updates
-
Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Global Health - Analysts/Institutional Investor Meet/Con. Call Updates
-
Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Global Health
Key fundamentals
Evaluate the intrinsic value of Global Health Ltd stock
Name | March-25 | March-24 | March-23 | March-22 | March-21 |
---|---|---|---|---|---|
Assets | 3638.05 | 2907.979 | 2590.4047 | 1861.8816 | 1507.1095 |
Liabilities | 3638.05 | 2907.979 | 2590.4047 | 1861.8816 | 1507.1095 |
Equity | 53.717 | 53.701 | 53.639 | 50.6448 | 49.5858 |
Gross Profit | 765.016 | 497.35 | 402.2721 | 374.836 | 168.4379 |
Net Profit | 461.528 | 360.891 | 263.2452 | 218.784 | 57.285 |
Cash From Operating Activities | 527.666 | 340.64 | 430.5298 | 235.4034 | 200.8814 |
NPM(%) | 14.4 | 15.82 | 13.43 | 12.4 | 4.66 |
Revenue | 3204.146 | 2280.008 | 1959.4462 | 1764.2492 | 1227.3981 |
Expenses | 2439.13 | 1782.658 | 1557.1741 | 1389.4132 | 1058.9602 |
ROE(%) | 14.69 | 11.48 | 8.37 | 6.96 | 1.82 |
Corporate Action
XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
---|---|---|---|---|
22 Aug 2025 | 0.5 | 25 | 0 | 1243.3 |
Peers
Other companies within the same industry or sector that are comparable to Global Health Ltd
Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
---|---|---|---|---|---|---|
No Records Found |
Company Info
Our Company was incorporated as `Global Health Private Limited' on August 13, 2004 at New Delhi, India as a private limited company under the Companies Act, 1956 pursuant to a certificate of incorporation by the RoC. Our Company was then converted into a public limited company under the Companies Act, 2013, pursuant to a special resolution passed by our Shareholders in the EGM held on July 31, 2021 and consequently, the name of our Company was changed to `Global Health Limited' and a fresh certificate of incorporation dated August 11, 2021 was issued by the RoC.Milestones:2009Gurugram hospital was established2011-Received the NABH accreditation for Gurugram hospital-Received the NABL accreditation for Gurugram hospital2013-Carlyle (i.e., Investor Selling Shareholder) invested in our Company-1st Joint Commission International ("JCI") accreditation for the hospital at Gurugram2014-Received the NABH (blood bank) accreditation for Gurugram hospital-Entered into a 27-year lease for hospital at Indore2015-Temasek invested in our Company-Entered into a 15-year lease for hospital at Ranchi-Our subsidiary, GHPPL, entered into a 33-year concession agreement with Governor of Bihar for the development, operation and maintenance of a proposed hospital on public-private partnership at Patna2016-Received the NABH accreditation for Indore hospital-Entered into a 90-year lease for our hospital at Noida (which is under construction)2018Received the NABH accreditation for Ranchi hospital2019Commencement of operations of new hospital at Lucknow2020-Patna hospital's outpatient department facility launched-Gurugram hospital outpatient department pharmacy taken in-house-Received the Research Ethics NABH accreditation2021-Lucknow hospital outpatient department pharmacy taken in-house-Indore hospital outpatient department pharmacy taken in-house-Ranchi hospital outpatient department pharmacy taken in-house-Launch of outpatient department pharmacy at south Delhi clinic2022-Patna hospital's inpatient department facility commenced operations-Received the NABH accreditation for Lucknow hospital-Launch of Patna hospital outpatient department pharmacy 2020 -Global Health listed as a best performing ASX small cap. -Global Health's Lifecard featured in series of Product Snapshots in the Australian healthtech sector. -Global Health joins BP's approved integrator network, goes live with SafeScript 2022 -Global Health is announce that it has secured two significant contracts for Homeless Healthcare (WA) and Peninsula Health (VIC). -Global Health Secures Three Key Contracts with Private Hospitals in NSW and WA. -Global Health brings health management online with new software solutions 2024 -The Company Approved the acquisition of land in Mumbai'by MHADA. -The Ho'nble National Company Law Tribunal, New Delhi Branch, Approved of Merger between MHPL and GHL.
Our Company was incorporated as `Global Health Private Limited' on August 13, 2004 at New Delhi, India as a private limited company under the Companies Act, 1956 pursuant to a certificate of incorporation by the RoC. Our Company was then converted into a public limited company under the Companies Act, 2013, pursuant to a special resolution passed by our Shareholders in the EGM held on July 31, 2021 and consequently, the name of our Company was changed to `Global Health Limited' and a fresh certificate of incorporation dated August 11, 2021 was issued by the RoC.Milestones:2009Gurugram hospital was established2011-Received the NABH accreditation for Gurugram hospital-Received the NABL accreditation for Gurugram hospital2013-Carlyle (i.e., Investor Selling Shareholder) invested in our Company-1st Joint Commission International ("JCI") accreditation for the hospital at Gurugram2014-Received the NABH (blood bank) accreditation for Gurugram hospital-Entered into a 27-year lease for hospital at Indore2015-Temasek invested in our Company-Entered into a 15-year lease for hospital at Ranchi-Our subsidiary, GHPPL, entered into a 33-year concession agreement with Governor of Bihar for the development, operation and maintenance of a proposed hospital on public-private partnership at Patna2016-Received the NABH accreditation for Indore hospital-Entered into a 90-year lease for our hospital at Noida (which is under construction)2018Received the NABH accreditation for Ranchi hospital2019Commencement of operations of new hospital at Lucknow2020-Patna hospital's outpatient department facility launched-Gurugram hospital outpatient department pharmacy taken in-house-Received the Research Ethics NABH accreditation2021-Lucknow hospital outpatient department pharmacy taken in-house-Indore hospital outpatient department pharmacy taken in-house-Ranchi hospital outpatient department pharmacy taken in-house-Launch of outpatient department pharmacy at south Delhi clinic2022-Patna hospital's inpatient department facility commenced operations-Received the NABH accreditation for Lucknow hospital-Launch of Patna hospital outpatient department pharmacy 2020 -Global Health listed as a best performing ASX small cap. -Global Health's Lifecard featured in series of Product Snapshots in the Australian healthtech sector. -Global Health joins BP's approved integrator network, goes live with SafeScript 2022 -Global Health is announce that it has secured two significant contracts for Homeless Healthcare (WA) and Peninsula Health (VIC). -Global Health Secures Three Key Contracts with Private Hospitals in NSW and WA. -Global Health brings health management online with new software solutions 2024 -The Company Approved the acquisition of land in Mumbai'by MHADA. -The Ho'nble National Company Law Tribunal, New Delhi Branch, Approved of Merger between MHPL and GHL.
Read More
Parent Organisation
Global Health Ltd.
Founded
13/08/2004
Managing Director
Dr.Naresh Trehan
NSE Symbol
MEDANTAEQ
FAQ
The current price of Global Health Ltd is ₹ 1374.00.
The 52-week high for Global Health Ltd is ₹ 1409.70 and the 52-week low is ₹ 1365.30.
The market capitalization of Global Health Ltd is currently ₹ 36931.80. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Global Health Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Global Health Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Global Health Ltd shares.
The CEO of Global Health Ltd is Dr.Naresh Trehan, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.